Project Details
Description
An Extension Treatment Protocol for Subjects who have Participated in a Phase 3 Study of Tivozanib vs Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301)
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/10 → 12/31/12 |
Funding
- AVEO PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.